Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion type Assertion NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_head.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion description "[Metformin was administered by gavage or in the diet, at a human equivalent dose, in standard mammary cancer models: (i) methylnitrosourea (MNU)-induced estrogen receptor-positive (ER(+)) mammary cancers in rats, and (ii) MMTV-Neu/p53KO ER(-) (estrogen receptor-negative) mammary cancers in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_provenance.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion evidence source_evidence_literature NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_provenance.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion SIO_000772 25681088 NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_provenance.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion wasDerivedFrom befree-2016 NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_provenance.
- NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_assertion wasGeneratedBy ECO_0000203 NP1263582.RAKYOCCb83J3KR6vMAPy8c7HEoI8fQTgS2hGGr_TFHTm0130_provenance.